Warren R W, Davie J M
J Immunol. 1977 Nov;119(5):1806-12.
Activated T lymphocytes (ATC) suppressed the expression of high avidity plaque-forming cells (PFC) in the secondary immune response when given in vivo 1 day before assay or when mixed in vitro with hyperimmune cells for 90 min before assay. This late acting suppression is a cell dose-dependent, carrier-spedific, T cell-mediated phenomenon. The target of this activity if probably the antibody-secreting cell.
活化的T淋巴细胞(ATC)在检测前1天体内给药时,或在检测前与超免疫细胞体外混合90分钟时,会抑制二次免疫反应中高亲和力噬斑形成细胞(PFC)的表达。这种晚期作用的抑制是一种细胞剂量依赖性、载体特异性、T细胞介导的现象。这种活性的靶标可能是抗体分泌细胞。